O’Melveny has advised Cantor Fitzgerald & Co.; DLA Piper has advised ACP Holdings Acquisition Corp.; Latham & Watkins has advised May Mobility. May Mobility, Inc., a...
May Mobility and ACP Holdings Announce $1.4 Billion Business Combination
Via Transportation Announces Pricing of US IPO
Skadden has advised Via Transportation, Inc. Latham & Watkins has advised the underwriters. Via Transportation, Inc. has announced the pricing of its initial public offering of...
Abivax Completes $747.5 Million Public Offering on Nasdaq
Dechert has advised Abivax. Cooley LLP has advised Abivax on U.S. law. Latham & Watkins LLP and Gide Loyrette Nouel A.A.R.P.I. have advised the underwriters. French...
ArriVent BioPharma Conducts $75 Million Public Offering
Mintz has advised ArriVent BioPharma, Inc. on the offering, and Latham & Watkins has advised the underwriters. ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, has announced...
Concentra’s $529 Million Initial Public Offering
Dechert advised Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. on the transaction, while Latham & Watkins advised the underwriters. Medical Holdings Corporation (“Select...
IO Biotech’s $75 Million Private Placement Financing
Sidley Austin advised IO Biotech, and Latham & Watkins advised the placement agents. IO Biotech, Inc. (Nasdaq: IOBT) announced that it has entered into a definitive...
ODDITY Tech’s $424 Million IPO
Herzog Fox & Neeman and Latham & Watkins LLP are advising ODDITY Tech Ltd., while Davis Polk & Wardwell and Goldfarb Gross Seligman & Co. are...
AlloVir’s $75 Million Common Stock Public Offering
Goodwin Procter represented AlloVir, and Latham & Watkins represented the underwriters in the offering. AlloVir, Inc. (Nasdaq: ALVR) announced the pricing of an underwritten public offering...
RadNet’s $259.2 Million Common Stock Public Offering
Sheppard Mullin represented RadNet, and Latham & Watkins represented the underwriters. RadNet, Inc. (NASDAQ: RDNT) has announced the closing of its underwritten public offering of 8,711,250 shares...
CureVac’s $250 Million Common Shares Offering
NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...
Roivant Sciences’ $230 Million Common Shares Offering
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
Rallybio’s $50 Million Common Stock Offering
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...